<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>26 Chemoradiation | GI Surgical Oncology</title>
  <meta name="description" content="Orientation Manual for GI Surgical Oncology Service" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="26 Chemoradiation | GI Surgical Oncology" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://github.com/gisurgonc/orientation" />
  
  <meta property="og:description" content="Orientation Manual for GI Surgical Oncology Service" />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="26 Chemoradiation | GI Surgical Oncology" />
  
  <meta name="twitter:description" content="Orientation Manual for GI Surgical Oncology Service" />
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="120x120" href="images/icon120.png" />
  <link rel="shortcut icon" href="images/favicon.io" type="image/x-icon" />
<link rel="prev" href="locally_advanced.html"/>
<link rel="next" href="radiation.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.5.1/jquery-3.5.1.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li>GI Surgical Oncology</li>

<li class="divider"></li>
<li><a href="index.html#Intro" id="toc-Intro"><span class="toc-section-number">1</span> Overview</a>
<ul>
<li><a href="index.html#absences" id="toc-absences"><span class="toc-section-number">1.1</span> Absences</a></li>
<li><a href="index.html#communication" id="toc-communication"><span class="toc-section-number">1.2</span> Communication</a></li>
<li><a href="index.html#inpatients" id="toc-inpatients"><span class="toc-section-number">1.3</span> Inpatients</a></li>
<li><a href="index.html#er-admits" id="toc-er-admits"><span class="toc-section-number">1.4</span> ER admits</a></li>
<li><a href="index.html#medical-records" id="toc-medical-records"><span class="toc-section-number">1.5</span> Medical Records</a></li>
<li><a href="index.html#operative-logs" id="toc-operative-logs"><span class="toc-section-number">1.6</span> Operative Logs</a></li>
<li><a href="index.html#case-assignment" id="toc-case-assignment"><span class="toc-section-number">1.7</span> Case Assignment</a></li>
<li><a href="index.html#clinic" id="toc-clinic"><span class="toc-section-number">1.8</span> Clinic</a></li>
<li><a href="index.html#work-hours" id="toc-work-hours"><span class="toc-section-number">1.9</span> Work Hours</a></li>
</ul></li>
<li><a href="cmc-inpatient.html#cmc-inpatient" id="toc-cmc-inpatient"><span class="toc-section-number">2</span> CMC Inpatient</a>
<ul>
<li><a href="cmc-inpatient.html#admissions" id="toc-admissions"><span class="toc-section-number">2.1</span> Admissions</a></li>
<li><a href="cmc-inpatient.html#rounds" id="toc-rounds"><span class="toc-section-number">2.2</span> Rounds</a></li>
<li><a href="cmc-inpatient.html#resident-epic-teams" id="toc-resident-epic-teams"><span class="toc-section-number">2.3</span> Resident Epic teams:</a></li>
<li><a href="cmc-inpatient.html#attending-epic-teams" id="toc-attending-epic-teams"><span class="toc-section-number">2.4</span> Attending Epic teams:</a></li>
<li><a href="cmc-inpatient.html#consults" id="toc-consults"><span class="toc-section-number">2.5</span> Consults</a></li>
<li><a href="cmc-inpatient.html#postop-clinic-appt" id="toc-postop-clinic-appt"><span class="toc-section-number">2.6</span> Postop Clinic Appt</a></li>
<li><a href="cmc-inpatient.html#conferences" id="toc-conferences"><span class="toc-section-number">2.7</span> Conferences</a></li>
</ul></li>
<li><a href="pineville-inpatient.html#pineville-inpatient" id="toc-pineville-inpatient"><span class="toc-section-number">3</span> Pineville Inpatient</a>
<ul>
<li><a href="pineville-inpatient.html#rounds-1" id="toc-rounds-1"><span class="toc-section-number">3.1</span> Rounds</a></li>
<li><a href="pineville-inpatient.html#resident-epic-teams-1" id="toc-resident-epic-teams-1"><span class="toc-section-number">3.2</span> Resident Epic teams:</a></li>
<li><a href="pineville-inpatient.html#consults-1" id="toc-consults-1"><span class="toc-section-number">3.3</span> Consults</a></li>
<li><a href="pineville-inpatient.html#postop-clinic-appts" id="toc-postop-clinic-appts"><span class="toc-section-number">3.4</span> Postop Clinic Appts</a></li>
<li><a href="pineville-inpatient.html#conferences-1" id="toc-conferences-1"><span class="toc-section-number">3.5</span> Conferences</a></li>
</ul></li>
<li><a href="rounds-2.html#rounds-2" id="toc-rounds-2"><span class="toc-section-number">4</span> Rounds</a></li>
<li><a href="progress-notes.html#progress-notes" id="toc-progress-notes"><span class="toc-section-number">5</span> Progress Notes</a></li>
<li><a href="discharges.html#discharges" id="toc-discharges"><span class="toc-section-number">6</span> Discharges</a></li>
<li><a href="education.html#education" id="toc-education"><span class="toc-section-number">7</span> Education</a>
<ul>
<li><a href="education.html#student-emr-notes-policy" id="toc-student-emr-notes-policy"><span class="toc-section-number">7.0.1</span> Student EMR Notes Policy</a></li>
</ul></li>
<li><a href="clinic-1.html#clinic-1" id="toc-clinic-1"><span class="toc-section-number">8</span> Clinic</a>
<ul>
<li><a href="clinic-1.html#salo-clinic" id="toc-salo-clinic"><span class="toc-section-number">8.1</span> Salo Clinic</a></li>
</ul></li>
<li><a href="mie_postop.html#mie_postop" id="toc-mie_postop"><span class="toc-section-number">9</span> Postop Care after Esophagectomy</a>
<ul>
<li><a href="mie_postop.html#weaning-tube-feeds-in-diabetics" id="toc-weaning-tube-feeds-in-diabetics"><span class="toc-section-number">9.1</span> Weaning Tube Feeds in Diabetics</a></li>
</ul></li>
<li><a href="#part-postoperative-care" id="toc-part-postoperative-care">(PART*) Postoperative Care</a></li>
<li><a href="colectomy.html#colectomy" id="toc-colectomy"><span class="toc-section-number">10</span> Colectomy</a></li>
<li><a href="lar-ileostomy.html#lar-ileostomy" id="toc-lar-ileostomy"><span class="toc-section-number">11</span> LAR + Ileostomy</a></li>
<li><a href="abdominoperineal-resection.html#abdominoperineal-resection" id="toc-abdominoperineal-resection"><span class="toc-section-number">12</span> Abdominoperineal Resection</a></li>
<li><a href="esophagectomy-postop.html#esophagectomy-postop" id="toc-esophagectomy-postop"><span class="toc-section-number">13</span> Esophagectomy Postop</a></li>
<li><a href="esophagectomy-ward.html#esophagectomy-ward" id="toc-esophagectomy-ward"><span class="toc-section-number">14</span> Esophagectomy Ward</a>
<ul>
<li><a href="esophagectomy-ward.html#anti-hypertensives" id="toc-anti-hypertensives"><span class="toc-section-number">14.1</span> Anti-Hypertensives</a></li>
<li><a href="esophagectomy-ward.html#chest-tubes" id="toc-chest-tubes"><span class="toc-section-number">14.2</span> Chest tubes</a></li>
<li><a href="esophagectomy-ward.html#gi-medicines" id="toc-gi-medicines"><span class="toc-section-number">14.3</span> GI Medicines</a></li>
<li><a href="esophagectomy-ward.html#leak_evaluation" id="toc-leak_evaluation"><span class="toc-section-number">14.4</span> Evaluation for leak</a>
<ul>
<li><a href="esophagectomy-ward.html#drain_amylase" id="toc-drain_amylase"><span class="toc-section-number">14.4.1</span> Drain Amylase</a></li>
<li><a href="esophagectomy-ward.html#ct_esophagram" id="toc-ct_esophagram"><span class="toc-section-number">14.4.2</span> CT esophagram</a></li>
</ul></li>
<li><a href="esophagectomy-ward.html#anastomotic-leak-treatment" id="toc-anastomotic-leak-treatment"><span class="toc-section-number">14.5</span> Anastomotic Leak Treatment</a></li>
</ul></li>
<li><a href="jejunostomy-feedings.html#jejunostomy-feedings" id="toc-jejunostomy-feedings"><span class="toc-section-number">15</span> Jejunostomy Feedings</a>
<ul>
<li><a href="jejunostomy-feedings.html#med-administration-via-j-tubes" id="toc-med-administration-via-j-tubes"><span class="toc-section-number">15.1</span> Med Administration via J-Tubes</a></li>
<li><a href="jejunostomy-feedings.html#occluded-jejunostomy-tubes" id="toc-occluded-jejunostomy-tubes"><span class="toc-section-number">15.2</span> Occluded Jejunostomy Tubes</a></li>
<li><a href="jejunostomy-feedings.html#jejunostomy_diabetes" id="toc-jejunostomy_diabetes"><span class="toc-section-number">15.3</span> Jejunostomy + Diabetes</a></li>
</ul></li>
<li><a href="#part-hill-or" id="toc-part-hill-or">(PART*) Hill OR</a></li>
<li><a href="colorectal-cases---hill.html#colorectal-cases---hill" id="toc-colorectal-cases---hill"><span class="toc-section-number">16</span> Colorectal Cases - Hill</a></li>
<li><a href="#part-salo-or" id="toc-part-salo-or">(PART*) Salo OR</a></li>
<li><a href="cv_port_salo.html#cv_port_salo" id="toc-cv_port_salo"><span class="toc-section-number">17</span> Central Venous Port (IJ)</a></li>
<li><a href="lap-jejunostomy.html#lap-jejunostomy" id="toc-lap-jejunostomy"><span class="toc-section-number">18</span> Lap Jejunostomy</a></li>
<li><a href="lap_gastrostomy_salo.html#lap_gastrostomy_salo" id="toc-lap_gastrostomy_salo"><span class="toc-section-number">19</span> Lap Gastrostomy</a></li>
<li><a href="esophagectomy-1-stage.html#esophagectomy-1-stage" id="toc-esophagectomy-1-stage"><span class="toc-section-number">20</span> Esophagectomy 1 Stage</a>
<ul>
<li><a href="esophagectomy-1-stage.html#indications" id="toc-indications"><span class="toc-section-number">20.1</span> Indications</a></li>
<li><a href="esophagectomy-1-stage.html#room-prep" id="toc-room-prep"><span class="toc-section-number">20.2</span> Room Prep</a>
<ul>
<li><a href="esophagectomy-1-stage.html#time-out" id="toc-time-out"><span class="toc-section-number">20.2.1</span> Time Out</a></li>
</ul></li>
<li><a href="esophagectomy-1-stage.html#gastric-mobilization" id="toc-gastric-mobilization"><span class="toc-section-number">20.3</span> Gastric Mobilization</a>
<ul>
<li><a href="esophagectomy-1-stage.html#distal-mobilization" id="toc-distal-mobilization"><span class="toc-section-number">20.3.1</span> Distal mobilization</a></li>
<li><a href="esophagectomy-1-stage.html#left-gastric-artery" id="toc-left-gastric-artery"><span class="toc-section-number">20.3.2</span> Left gastric artery</a></li>
<li><a href="esophagectomy-1-stage.html#mediastinal-dissection" id="toc-mediastinal-dissection"><span class="toc-section-number">20.3.3</span> Mediastinal dissection</a></li>
<li><a href="esophagectomy-1-stage.html#division-of-esophagus-four-phase" id="toc-division-of-esophagus-four-phase"><span class="toc-section-number">20.3.4</span> Division of Esophagus (Four-Phase)</a></li>
<li><a href="esophagectomy-1-stage.html#entry-into-right-chest" id="toc-entry-into-right-chest"><span class="toc-section-number">20.3.5</span> Entry into right chest</a></li>
</ul></li>
</ul></li>
<li><a href="#part-esophageal-cancer" id="toc-part-esophageal-cancer">(PART*) Esophageal Cancer</a></li>
<li><a href="EsoIntro.html#EsoIntro" id="toc-EsoIntro"><span class="toc-section-number">21</span> Esophageal Overview</a></li>
<li><a href="staging.html#staging" id="toc-staging"><span class="toc-section-number">22</span> Staging</a></li>
<li><a href="superficial.html#superficial" id="toc-superficial"><span class="toc-section-number">23</span> Superficial EsoCa</a>
<ul>
<li><a href="superficial.html#emr" id="toc-emr"><span class="toc-section-number">23.1</span> Endscopic Mucosal Resection (EMR)</a></li>
</ul></li>
<li><a href="localized.html#localized" id="toc-localized"><span class="toc-section-number">24</span> Localized EsoCa</a>
<ul>
<li><a href="localized.html#t1b-tumors" id="toc-t1b-tumors"><span class="toc-section-number">24.1</span> T1b Tumors</a></li>
<li><a href="localized.html#t2n0-tumors" id="toc-t2n0-tumors"><span class="toc-section-number">24.2</span> T2N0 Tumors</a></li>
<li><a href="localized.html#staging-of-t2n0-tumors" id="toc-staging-of-t2n0-tumors"><span class="toc-section-number">24.3</span> Staging of T2N0 Tumors</a></li>
</ul></li>
<li><a href="locally_advanced.html#locally_advanced" id="toc-locally_advanced"><span class="toc-section-number">25</span> Locally Advanced EsoCa</a>
<ul>
<li><a href="locally_advanced.html#trimodality" id="toc-trimodality"><span class="toc-section-number">25.1</span> Trimodality Therapy</a>
<ul>
<li><a href="locally_advanced.html#neoadjuvant-chemort-for-scca" id="toc-neoadjuvant-chemort-for-scca"><span class="toc-section-number">25.1.1</span> Neoadjuvant chemoRT for SCCA</a></li>
<li><a href="locally_advanced.html#neoadjuvant-chemotheraphy-followed-by-surgery" id="toc-neoadjuvant-chemotheraphy-followed-by-surgery"><span class="toc-section-number">25.1.2</span> Neoadjuvant chemotheraphy followed by surgery</a></li>
</ul></li>
<li><a href="locally_advanced.html#ge-junction" id="toc-ge-junction"><span class="toc-section-number">25.2</span> GE Junction</a></li>
<li><a href="locally_advanced.html#induction-chemotherapy-followed-by-chemort" id="toc-induction-chemotherapy-followed-by-chemort"><span class="toc-section-number">25.3</span> Induction chemotherapy followed by chemoRT</a></li>
<li><a href="locally_advanced.html#postoperative-chemoradiation" id="toc-postoperative-chemoradiation"><span class="toc-section-number">25.4</span> Postoperative chemoradiation</a></li>
</ul></li>
<li><a href="eso_dcrt.html#eso_dcrt" id="toc-eso_dcrt"><span class="toc-section-number">26</span> Chemoradiation</a>
<ul>
<li><a href="eso_dcrt.html#phase-ii-studies" id="toc-phase-ii-studies"><span class="toc-section-number">26.1</span> Phase II Studies</a></li>
<li><a href="eso_dcrt.html#chemort-vs-trimodality-therapy" id="toc-chemort-vs-trimodality-therapy"><span class="toc-section-number">26.2</span> ChemoRT vs Trimodality therapy</a></li>
</ul></li>
<li><a href="radiation.html#radiation" id="toc-radiation"><span class="toc-section-number">27</span> Radiation</a></li>
<li><a href="esophagectomy.html#esophagectomy" id="toc-esophagectomy"><span class="toc-section-number">28</span> Esophagectomy</a>
<ul>
<li><a href="esophagectomy.html#preoperative-evaluation" id="toc-preoperative-evaluation"><span class="toc-section-number">28.0.1</span> Preoperative Evaluation</a></li>
<li><a href="esophagectomy.html#minimally-invasive-esophagectomy" id="toc-minimally-invasive-esophagectomy"><span class="toc-section-number">28.1</span> Minimally-invasive Esophagectomy</a></li>
<li><a href="esophagectomy.html#transthoracic" id="toc-transthoracic"><span class="toc-section-number">28.2</span> Transthoracic</a></li>
<li><a href="esophagectomy.html#transhiatal" id="toc-transhiatal"><span class="toc-section-number">28.3</span> Transhiatal</a></li>
<li><a href="esophagectomy.html#three-hole" id="toc-three-hole"><span class="toc-section-number">28.4</span> Three-hole</a></li>
<li><a href="esophagectomy.html#extended-lymphadenectomy" id="toc-extended-lymphadenectomy"><span class="toc-section-number">28.5</span> Extended lymphadenectomy</a></li>
<li><a href="esophagectomy.html#early-recovery-pathways" id="toc-early-recovery-pathways"><span class="toc-section-number">28.6</span> Early Recovery Pathways</a></li>
<li><a href="esophagectomy.html#salvage-esophagectomy" id="toc-salvage-esophagectomy"><span class="toc-section-number">28.7</span> Salvage esophagectomy</a></li>
</ul></li>
<li><a href="eso_metastatic.html#eso_metastatic" id="toc-eso_metastatic"><span class="toc-section-number">29</span> Metastatic EsoCa</a>
<ul>
<li><a href="eso_metastatic.html#palliative-radiation" id="toc-palliative-radiation"><span class="toc-section-number">29.1</span> Palliative radiation</a></li>
<li><a href="eso_metastatic.html#chemoradiation-vs-chemotherapy-in-stage-iv" id="toc-chemoradiation-vs-chemotherapy-in-stage-iv"><span class="toc-section-number">29.2</span> Chemoradiation vs chemotherapy in Stage IV</a></li>
<li><a href="eso_metastatic.html#stents-for-malignant-disease" id="toc-stents-for-malignant-disease"><span class="toc-section-number">29.3</span> Stents for malignant disease</a></li>
</ul></li>
<li><a href="eso_survivorship.html#eso_survivorship" id="toc-eso_survivorship"><span class="toc-section-number">30</span> Survivorship</a>
<ul>
<li><a href="eso_survivorship.html#nutritional-consequences-of-esophagectomy" id="toc-nutritional-consequences-of-esophagectomy"><span class="toc-section-number">30.1</span> Nutritional consequences of esophagectomy</a>
<ul>
<li><a href="eso_survivorship.html#vitamin-d-deficiency" id="toc-vitamin-d-deficiency"><span class="toc-section-number">30.1.1</span> Vitamin D deficiency</a></li>
</ul></li>
<li><a href="eso_survivorship.html#cardiac-toxicity-of-radiation" id="toc-cardiac-toxicity-of-radiation"><span class="toc-section-number">30.2</span> Cardiac toxicity of radiation</a></li>
<li><a href="eso_survivorship.html#eso_surveillance" id="toc-eso_surveillance"><span class="toc-section-number">30.3</span> Surveillance</a></li>
</ul></li>
<li><a href="#part-gastric-cancer" id="toc-part-gastric-cancer">(PART*) Gastric Cancer</a></li>
<li><a href="gastric-overview.html#gastric-overview" id="toc-gastric-overview"><span class="toc-section-number">31</span> Gastric Overview</a></li>
<li><a href="gast_superficial.html#gast_superficial" id="toc-gast_superficial"><span class="toc-section-number">32</span> Superficial Gastric</a></li>
<li><a href="locally-advanced-gastric.html#locally-advanced-gastric" id="toc-locally-advanced-gastric"><span class="toc-section-number">33</span> Locally-Advanced Gastric</a>
<ul>
<li><a href="locally-advanced-gastric.html#preoperative-chemotherapy" id="toc-preoperative-chemotherapy"><span class="toc-section-number">33.1</span> Preoperative Chemotherapy</a></li>
<li><a href="locally-advanced-gastric.html#postoperative-chemotherapy" id="toc-postoperative-chemotherapy"><span class="toc-section-number">33.2</span> Postoperative chemotherapy</a></li>
<li><a href="locally-advanced-gastric.html#postoperative-chemoradiation-1" id="toc-postoperative-chemoradiation-1"><span class="toc-section-number">33.3</span> Postoperative chemoradiation</a></li>
<li><a href="locally-advanced-gastric.html#preoperative-chemoradiation" id="toc-preoperative-chemoradiation"><span class="toc-section-number">33.4</span> Preoperative chemoradiation</a></li>
</ul></li>
<li><a href="hereditary-diffuse-gastric-cancer.html#hereditary-diffuse-gastric-cancer" id="toc-hereditary-diffuse-gastric-cancer"><span class="toc-section-number">34</span> Hereditary Diffuse Gastric Cancer</a></li>
<li><a href="#part-colon-cancer" id="toc-part-colon-cancer">(PART*) Colon Cancer</a></li>
<li><a href="colorectal-overview.html#colorectal-overview" id="toc-colorectal-overview"><span class="toc-section-number">35</span> Colorectal Overview</a></li>
<li><a href="colon-cancer-staging.html#colon-cancer-staging" id="toc-colon-cancer-staging"><span class="toc-section-number">36</span> Colon Cancer Staging</a>
<ul>
<li><a href="colon-cancer-staging.html#cea-level" id="toc-cea-level"><span class="toc-section-number">36.1</span> CEA level</a></li>
<li><a href="colon-cancer-staging.html#ct-scan" id="toc-ct-scan"><span class="toc-section-number">36.2</span> CT Scan</a></li>
<li><a href="colon-cancer-staging.html#pet-scan" id="toc-pet-scan"><span class="toc-section-number">36.3</span> PET scan</a>
<ul>
<li><a href="colon-cancer-staging.html#indications-for-pet-in-colorectal-cancer" id="toc-indications-for-pet-in-colorectal-cancer"><span class="toc-section-number">36.3.1</span> Indications for PET in colorectal cancer:</a></li>
</ul></li>
<li><a href="colon-cancer-staging.html#adjuvant-therapy" id="toc-adjuvant-therapy"><span class="toc-section-number">36.4</span> Adjuvant Therapy</a></li>
</ul></li>
<li><a href="stage-iv-colon-cancer.html#stage-iv-colon-cancer" id="toc-stage-iv-colon-cancer"><span class="toc-section-number">37</span> Stage IV Colon Cancer</a>
<ul>
<li><a href="stage-iv-colon-cancer.html#carcinomatosis" id="toc-carcinomatosis"><span class="toc-section-number">37.1</span> Carcinomatosis</a></li>
<li><a href="stage-iv-colon-cancer.html#colon-resection-in-stage-iv-colon-cancer" id="toc-colon-resection-in-stage-iv-colon-cancer"><span class="toc-section-number">37.2</span> Colon resection in stage IV colon cancer</a></li>
<li><a href="stage-iv-colon-cancer.html#immunotherapy-for-dmmr-msi-high" id="toc-immunotherapy-for-dmmr-msi-high"><span class="toc-section-number">37.3</span> Immunotherapy for dMMR (MSI high)</a></li>
</ul></li>
<li><a href="colectomy-1.html#colectomy-1" id="toc-colectomy-1"><span class="toc-section-number">38</span> Colectomy</a>
<ul>
<li><a href="colectomy-1.html#extended-node-dissection" id="toc-extended-node-dissection"><span class="toc-section-number">38.1</span> Extended Node dissection</a></li>
</ul></li>
<li><a href="chemotherapy.html#chemotherapy" id="toc-chemotherapy"><span class="toc-section-number">39</span> Chemotherapy</a>
<ul>
<li><a href="chemotherapy.html#neoadjuvant-chemotherapy" id="toc-neoadjuvant-chemotherapy"><span class="toc-section-number">39.1</span> Neoadjuvant Chemotherapy</a></li>
</ul></li>
<li><a href="#part-rectal-cancer" id="toc-part-rectal-cancer">(PART*) Rectal Cancer</a></li>
<li><a href="rectal-overview.html#rectal-overview" id="toc-rectal-overview"><span class="toc-section-number">40</span> Rectal Overview</a></li>
<li><a href="rectal-cancer-staging.html#rectal-cancer-staging" id="toc-rectal-cancer-staging"><span class="toc-section-number">41</span> Rectal Cancer Staging</a>
<ul>
<li><a href="rectal-cancer-staging.html#mri-staging" id="toc-mri-staging"><span class="toc-section-number">41.1</span> MRI staging</a></li>
</ul></li>
<li><a href="rectal-cancer-surgery.html#rectal-cancer-surgery" id="toc-rectal-cancer-surgery"><span class="toc-section-number">42</span> Rectal Cancer Surgery</a></li>
<li><a href="rectal-adjuvant-therapy.html#rectal-adjuvant-therapy" id="toc-rectal-adjuvant-therapy"><span class="toc-section-number">43</span> Rectal Adjuvant Therapy</a>
<ul>
<li><a href="rectal-adjuvant-therapy.html#short-course-preoperative-therapy" id="toc-short-course-preoperative-therapy"><span class="toc-section-number">43.0.1</span> Short-course preoperative therapy</a></li>
<li><a href="rectal-adjuvant-therapy.html#total-neoadjuvant-therapy" id="toc-total-neoadjuvant-therapy"><span class="toc-section-number">43.0.2</span> Total Neoadjuvant therapy</a></li>
<li><a href="rectal-adjuvant-therapy.html#neoadjuvant-immunotherapy-msi-high" id="toc-neoadjuvant-immunotherapy-msi-high"><span class="toc-section-number">43.1</span> Neoadjuvant immunotherapy (MSI high)</a></li>
<li><a href="rectal-adjuvant-therapy.html#non-operative-management-of-rectal-cancer" id="toc-non-operative-management-of-rectal-cancer"><span class="toc-section-number">43.2</span> Non-operative management of Rectal Cancer</a></li>
</ul></li>
<li><a href="#part-sarcoma" id="toc-part-sarcoma">(PART*) Sarcoma</a></li>
<li><a href="soft-tissue-sarcomas.html#soft-tissue-sarcomas" id="toc-soft-tissue-sarcomas"><span class="toc-section-number">44</span> Soft Tissue Sarcomas</a>
<ul>
<li><a href="soft-tissue-sarcomas.html#desmoid-tumors" id="toc-desmoid-tumors"><span class="toc-section-number">44.1</span> Desmoid Tumors</a></li>
<li><a href="soft-tissue-sarcomas.html#retroperitoneal" id="toc-retroperitoneal"><span class="toc-section-number">44.2</span> Retroperitoneal</a></li>
<li><a href="soft-tissue-sarcomas.html#peritoneal-mesothelioma" id="toc-peritoneal-mesothelioma"><span class="toc-section-number">44.3</span> Peritoneal mesothelioma</a></li>
</ul></li>
<li><a href="references.html#references" id="toc-references">References</a></li>
<li class="divider"></li>
<li><a href="mailto:jonathan.salo@atriumhealth.org">Feedback and Updates</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">GI Surgical Oncology</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="eso_dcrt" class="section level1" number="26">
<h1><span class="header-section-number">26</span> Chemoradiation</h1>
<p>**This section addresses chemoradiation as primary (definitive) therapy for esophageal cancer. See also <a href="locally_advanced.html#trimodality">Trimodality Therapy</a></p>
<div id="phase-ii-studies" class="section level2" number="26.1">
<h2><span class="header-section-number">26.1</span> Phase II Studies</h2>
<p>Experience with patients who refuse surgery or are medically unfit:</p>
<p>MD Anderson report of 61 patients out of 622 tri-modality-eligible patients who refused surgery after cCR. 5-year overall survival was 58%. 13 developped local recurrence during surveillance, and 12 had successful salvage esophagectomy <span class="citation">(<a href="#ref-taketa300" role="doc-biblioref">T. Taketa et al. 2012</a>)</span>. The same group compared those who underwent surgery vs definitive chemoradiation in a propensity-matched fashion<span class="citation">(<a href="#ref-taketa95" role="doc-biblioref">Takashi Taketa et al. 2013</a>)</span>. Irish study of 56 patients aged 70 or older treated with neoadjuvant chemoradiation followed by selective surgery. Median survival was 28 months overall, 47 months for those with cCR, 61 months for primary resection, 46 months for cCRs who did not undergo resection, and 29 months for those with salvage esophagectomy<span class="citation">(<a href="#ref-furlong107" role="doc-biblioref">Furlong et al. 2013</a>)</span>.</p>
<p>Castoro<span class="citation">(<a href="#ref-castoro1375" role="doc-biblioref">Castoro et al. 2013</a>)</span></p>
<p>preSANO<span class="citation">(<a href="#ref-chirieac1347" role="doc-biblioref">Chirieac et al. 2005</a>)</span> Clinical Response evaluation after chemoRT for esophageal cancer with PET and EGD.</p>
</div>
<div id="chemort-vs-trimodality-therapy" class="section level2" number="26.2">
<h2><span class="header-section-number">26.2</span> ChemoRT vs Trimodality therapy</h2>
<p>The sensitivity of squamous cell carcinoma of the esophagus to chemoradiation has raised the question whether</p>
<p>Stahl Locally advanced squamous cell carcinoma randomized to induction chemotherapy (cisplatin, etopiside, 5FU with leuocovrin) followed by chemoradiation (4000cGy with concurrent ciplatin and etopiside) followed by surgery compared with induction chemotherapy followed by chemoradiation (6400cGy with concurrent cisplatin and etopiside).<span class="citation">(<a href="#ref-stahl2310" role="doc-biblioref">Stahl et al. 2005</a>)</span> progression-free survival was better in the trimodality group (64.3% vs 40.7%) Treatment-related morality was substantial in the surgery arm (13% vs 4%). This would be considered an excessive rate of operative mortality by modern standards. Unsurprisingly, there was no difference in overall survival between groups, in part because the surgical group had an excess 9% mortality rate from treatment. Two-year survival in the surgery arm was 40% vs 35% in the definitive chemoradiation arm.</p>
<p>In the French FFCD trial, 444 patients with carcinoma of the esophagus (90% squamous cell) were treated with two cycles of 5-FU and cisplatin with concurrent radiation.<span class="citation">(<a href="#ref-bedenne1160" role="doc-biblioref">Bedenne et al. 2007</a>)</span> Patients with a partial or complete clinical response to chemoradiation were randomized to either surgery or a boost of radiation. Patients who did not respond to chemoradiation were treated with surgery and were eliminated from the study. Only 259 of the original 444 patients (59%) went on to randomization, with the remainder (those not responding to chemoradiation) treated with surgery. Of the randomized group, median survival was 17.7months in the surgery arm versus 19.3months in the definitive chemoradiation arm. Like the Stahl study, treatment-related mortality in the surgical arm was high (9% versus 1%).</p>
<p>#Active Surveillance</p>
<p>EGD is poor predictor of pCR <span class="citation">(<a href="#ref-sarkaria764" role="doc-biblioref">Sarkaria et al. 2009</a>)</span></p>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-bedenne1160" class="csl-entry">
Bedenne, Laurent, Pierre Michel, Olivier Bouché, Chantal Milan, Christophe Mariette, Thierry Conroy, Denis Pezet, et al. 2007. <span>“Chemoradiation Followed by Surgery Compared with Chemoradiation Alone in Squamous Cancer of the Esophagus: <span>FFCD</span> 9102.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 25 (10): 1160–68. <a href="https://doi.org/10.1200/JCO.2005.04.7118">https://doi.org/10.1200/JCO.2005.04.7118</a>.
</div>
<div id="ref-castoro1375" class="csl-entry">
Castoro, Carlo, Marco Scarpa, Matteo Cagol, Rita Alfieri, Alberto Ruol, Francesco Cavallin, Silvia Michieletto, et al. 2013. <span>“Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?”</span> <em>Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract</em> 17 (8): 1375–81. <a href="https://doi.org/10.1007/s11605-013-2269-3">https://doi.org/10.1007/s11605-013-2269-3</a>.
</div>
<div id="ref-chirieac1347" class="csl-entry">
Chirieac, Lucian R., Stephen G. Swisher, Jaffer A. Ajani, Ritsuko R. Komaki, Arlene M. Correa, Jeffrey S. Morris, Jack A. Roth, Asif Rashid, Stanley R. Hamilton, and Tsung-Teh Wu. 2005. <span>“Posttherapy Pathologic Stage Predicts Survival in Patients with Esophageal Carcinoma Receiving Preoperative Chemoradiation.”</span> <em>Cancer</em> 103 (7): 1347–55. <a href="https://doi.org/10.1002/cncr.20916">https://doi.org/10.1002/cncr.20916</a>.
</div>
<div id="ref-furlong107" class="csl-entry">
Furlong, Heidi, Gary Bass, Oscar Breathnach, Brian O’Neill, Eamonn Leen, and Thomas N. Walsh. 2013. <span>“Targeting Therapy for Esophageal Cancer in Patients Aged 70 and Over.”</span> <em>Journal of Geriatric Oncology</em> 4 (2): 107–13. <a href="https://doi.org/10.1016/j.jgo.2012.12.006">https://doi.org/10.1016/j.jgo.2012.12.006</a>.
</div>
<div id="ref-sarkaria764" class="csl-entry">
Sarkaria, Inderpal S., Nabil P. Rizk, Manjit S. Bains, Laura H. Tang, David H. Ilson, Bruce I. Minsky, and Valerie W. Rusch. 2009. <span>“Post-Treatment Endoscopic Biopsy Is a Poor-Predictor of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer.”</span> <em>Annals of Surgery</em> 249 (5): 764–67. <a href="https://doi.org/10.1097/SLA.0b013e3181a38e9e">https://doi.org/10.1097/SLA.0b013e3181a38e9e</a>.
</div>
<div id="ref-stahl2310" class="csl-entry">
Stahl, Michael, Martin Stuschke, Nils Lehmann, Hans-Joachim Meyer, Martin K. Walz, Siegfried Seeber, Bodo Klump, et al. 2005. <span>“Chemoradiation with and Without Surgery in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 23 (10): 2310–17. <a href="https://doi.org/10.1200/JCO.2005.00.034">https://doi.org/10.1200/JCO.2005.00.034</a>.
</div>
<div id="ref-taketa95" class="csl-entry">
Taketa, Takashi, Lianchun Xiao, Kazuki Sudo, Akihiro Suzuki, Roopma Wadhwa, Mariela A. Blum, Jeffrey H. Lee, et al. 2013. <span>“Propensity-Based Matching Between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery After Preoperative Chemoradiation.”</span> <em>Oncology</em> 85 (2): 95–99. <a href="https://doi.org/10.1159/000351999">https://doi.org/10.1159/000351999</a>.
</div>
<div id="ref-taketa300" class="csl-entry">
Taketa, T., A. M. Correa, A. Suzuki, M. A. Blum, P. Chien, J. H. Lee, J. Welsh, et al. 2012. <span>“Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery After Preoperative Chemoradiation.”</span> Journal {{Article}}. <em>Oncology</em> 83 (5): 300–304. <a href="https://doi.org/10.1159/000341353">https://doi.org/10.1159/000341353</a>.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="locally_advanced.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="radiation.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/jcsalo/gi_surgonc/edit/main/539-eso_dCRT.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["gi_surgonc.pdf", "gi_surgonc.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true,
"search": true,
"sharing": false
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
